Aaltonen LA, Peltomaki P, Leach FS et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260 (5109):812-6.
Aarnio M, Mecklin JP, Aaltonen LA et al. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 1995; 64 (6):430-3.
Aarnio M, Sankila R, Pukkala E et al. Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer 1999; 81 (2):214-8.
Ahmed FE. Gene-gene, gene-environment & multiple interactions in colorectal cancer. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2006; 24 (1):1-101.
Al-Tassan N, Chmiel NH, Maynard J et al. Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors. Nat Genet 2002; 30 (2):227-32.
Altman DG. Categorising continuous variables. Br J Cancer 1991; 64 (5):975.
Baglioni S, Genuardi M. Simple and complex genetics of colorectal cancer susceptibility. Am J Med Genet C Semin Med Genet 2004; 129 (1):35-43.
Baker SJ, Fearon ER, Nigro JM et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244 (4901):217-21.
Banerjee RV, Matthews RG. Cobalamin-dependent methionine synthase. Faseb J 1990; 4 (5):1450-9.
Baxter SW, Choong DY, Eccles DM et al. Transforming growth factor beta receptor 1 polyalanine polymorphism and exon 5 mutation analysis in breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 2002; 11 (2):211-4.
Berlin JA, Laird NM, Sacks HS et al. A comparison of statistical methods for combining event rates from clinical trials. Stat Med 1989; 8 (2):141-51.
Bian Y, Caldes T, Wijnen J et al. TGFBR1*6A may contribute to hereditary colorectal cancer. J Clin Oncol 2005; 23 (13):3074-8.
Bisgaard ML, Jager AC, Myrhoj T et al. Hereditary non-polyposis colorectal cancer (HNPCC):
phenotype-genotype correlation between patients with and without identified mutation. Hum Mutat 2002; 20 (1):20-7.
Bodmer WF, Bailey CJ, Bodmer J et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328 (6131):614-6.
Boland CR, Thibodeau SN, Hamilton SR et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.
Cancer Res 1998; 58 (22):5248-57.
Bos JL. ras oncogenes in human cancer: a review. Cancer Res 1989; 49 (17):4682-9.
Breivik J, Gaudernack G. Genomic instability, DNA methylation, and natural selection in colorectal carcinogenesis. Semin Cancer Biol 1999; 9 (4):245-54.
Bulow S, Faurschou Nielsen T, Bulow C et al. The incidence rate of familial adenomatous polyposis. Results from the Danish Polyposis Register. Int J Colorectal Dis 1996; 11 (2):88-91.
Burt RW, Leppert MF, Slattery ML et al. Genetic testing and phenotype in a large kindred with attenuated familial adenomatous polyposis. Gastroenterology 2004; 127 (2):444-51.
Ceccherini-Nelli L, De Re V, Viel A et al. Ha-ras-1 restriction fragment length polymorphism and susceptibility to colon adenocarcinoma. Br J Cancer 1987; 56 (1):1-5.
Chan TL, Yuen ST, Kong CK et al. Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer. Nat Genet 2006; 38 (10):1178-83.
Chen J, Giovannucci E, Hankinson SE et al. A prospective study of methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms, and risk of colorectal adenoma.
Carcinogenesis 1998; 19 (12):2129-32.
Chen J, Giovannucci E, Kelsey K et al. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer. Cancer Res 1996; 56 (21):4862-4.
Chen T, de Vries EG, Hollema H et al. Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 1999; 82 (1):43-51.
Chen T, Jackson C, Costello B et al. An intronic variant of the TGFBR1 gene is associated with carcinomas of the kidney and bladder. Int J Cancer 2004; 112 (3):420-5.
Chen T, Triplett J, Dehner B et al. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas. Cancer Res 2001; 61 (12):4679-82.
Chmiel NH, Livingston AL, David SS. Insight into the functional consequences of inherited variants of the hMYH adenine glycosylase associated with colorectal cancer: complementation assays with hMYH variants and pre-steady-state kinetics of the corresponding mutated E.coli enzymes. J Mol Biol 2003; 327 (2):431-43.
Coburn MC, Pricolo VE, DeLuca FG et al. Malignant potential in intestinal juvenile polyposis syndromes. Ann Surg Oncol 1995; 2 (5):386-91.
Cohen D, Chumakov I, Weissenbach J. A first-generation physical map of the human genome.
Nature 1993; 366 (6456):698-701.
Cormier RT, Hong KH, Halberg RB et al. Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis. Nat Genet 1997; 17 (1):88-91.
Cottingham RW, Jr., Idury RM, Schaffer AA. Faster sequential genetic linkage computations.
Am J Hum Genet 1993; 53 (1):252-63.
Cui H, Cruz-Correa M, Giardiello FM et al. Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science 2003; 299 (5613):1753-5.
Cuzick J. A method for analysing case-control studies with ordinal exposure variables.
Biometrics 1985; 41 (3):609-21.
de Jong MM, Nolte IM, te Meerman GJ et al. Low-penetrance genes and their involvement in colorectal cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2002; 11 (11):1332-52.
de la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer 2004; 4 (10):769-80.
de la Chapelle A. The incidence of Lynch syndrome. Fam Cancer 2005; 4 (3):233-7.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7 (3):177-88.
Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29 (2):117-29.
Desai DC, Neale KF, Talbot IC et al. Juvenile polyposis. Br J Surg 1995; 82 (1):14-7.
Dietrich WF, Lander ES, Smith JS et al. Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse. Cell 1993; 75 (4):631-9.
Djureinovic T, Skoglund J, Vandrovcova J et al. A genome wide linkage analysis in Swedish families with hereditary non-familial adenomatous polyposis/non-hereditary non-polyposis colorectal cancer. Gut 2006; 55 (3):362-6.
Drummond JT, Li GM, Longley MJ et al. Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science 1995; 268 (5219):1909-12.
Egger G, Liang G, Aparicio A et al. Epigenetics in human disease and prospects for epigenetic therapy. Nature 2004; 429 (6990):457-63.
Egger M, Davey Smith G, Schneider M et al. Bias in meta-analysis detected by a simple, graphical test. Bmj 1997; 315 (7109):629-34.
Eliason K, Hendrickson BC, Judkins T et al. The potential for increased clinical sensitivity in genetic testing for polyposis colorectal cancer through the analysis of MYH mutations in North American patients. J Med Genet 2005; 42 (1):95-6.
Eppert K, Scherer SW, Ozcelik H et al. MADR2 maps to 18q21 and encodes a TGFbeta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 1996;
86 (4):543-52.
Eshleman JR, Markowitz SD. Mismatch repair defects in human carcinogenesis. Hum Mol Genet 1996; 5 Spec No:1489-94.
Farrington SM, Tenesa A, Barnetson R et al. Germline susceptibility to colorectal cancer due to base-excision repair gene defects. Am J Hum Genet 2005; 77 (1):112-9.
Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001; 10 (7):721-33.
Fearon ER, Hamilton SR, Vogelstein B. Clonal analysis of human colorectal tumors. Science 1987; 238 (4824):193-7.
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990; 61 (5):759-67.
Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7 (1):21-33.
Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4 (2):143-53.
Fishel R, Lescoe MK, Rao MR et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993; 75 (5):1027-38.
Fleiss JL, Tutyn, A., Uray, H.K. A simple approximation for calculating sample sizes for comparing independent proportions. Biometrics 1980; 36:343-6.
Franzen P, ten Dijke P, Ichijo H et al. Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor. Cell 1993; 75 (4):681-92.
Frayling IM, Beck NE, Ilyas M et al. The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci U S A 1998;
95 (18):10722-7.
Giardiello FM, Brensinger JD, Tersmette AC et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology 2000; 119 (6):1447-53.
Giardiello FM, Krush AJ, Petersen GM et al. Phenotypic variability of familial adenomatous polyposis in 11 unrelated families with identical APC gene mutation. Gastroenterology 1994;
106 (6):1542-7.
Giovannucci E. Modifiable risk factors for colon cancer. Gastroenterol Clin North Am 2002; 31 (4):925-43.
Gosse-Brun S, Sauvaigo S, Daver A et al. Association between H-ras minisatellite and colorectal cancer risk. Anticancer Res 1998; 18 (4A):2611-6.
Grady WM, Markowitz SD. Hereditary colon cancer genes. Methods Mol Biol 2003; 222:59-83.
Grady WM, Myeroff LL, Swinler SE et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 1999; 59 (2):320-4.
Grady WM, Rajput A, Myeroff L et al. Mutation of the type II transforming growth factor-beta receptor is coincident with the transformation of human colon adenomas to malignant
carcinomas. Cancer Res 1998; 58 (14):3101-4.
Groden J, Thliveris A, Samowitz W et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66 (3):589-600.
Gryfe R, Di Nicola N, Lal G et al. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet 1999; 64 (2):378-84.
Haenszel W. Cancer mortality among the foreign-born in the United States. J Natl Cancer Inst 1961; 26:37-132.
Hampel H, Stephens JA, Pukkala E et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology 2005; 129 (2):415-21.
Hemminki K, Lonnstedt I, Vaittinen P et al. Estimation of genetic and environmental components in colorectal and lung cancer and melanoma. Genet Epidemiol 2001; 20 (1):107-16.
Herrera L, Kakati S, Gibas L et al. Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986; 25 (3):473-6.
Hitchins M, Williams R, Cheong K et al. MLH1 germline epimutations as a factor in hereditary nonpolyposis colorectal cancer. Gastroenterology 2005; 129 (5):1392-9.
Hoang JM, Cottu PH, Thuille B et al. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997; 57 (2):300-3.
Houlston RS, Peto J. The future of association studies of common cancers. Hum Genet 2003;
112 (4):434-5.
Houlston RS, Tomlinson IP. Polymorphisms and colorectal tumor risk. Gastroenterology 2001;
121 (2):282-301.
Huang CS, O'Brien M J, Yang S et al. Hyperplastic polyps, serrated adenomas, and the serrated polyp neoplasia pathway. Am J Gastroenterol 2004; 99 (11):2242-55.
Ionov Y, Peinado MA, Malkhosyan S et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363 (6429):558-61.
Jacobson JS, Neugut AI. Epidemiology of gastrointestinal polyps. Surg Oncol Clin N Am 1996;
5 (3):531-44.
Jacques PF, Bostom AG, Williams RR et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations.
Circulation 1996; 93 (1):7-9.
Jaeger EE, Woodford-Richens KL, Lockett M et al. An ancestral Ashkenazi haplotype at the HMPS/CRAC1 locus on 15q13-q14 is associated with hereditary mixed polyposis syndrome.
Am J Hum Genet 2003; 72 (5):1261-7.
Jass JR, Iino H, Ruszkiewicz A et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut 2000; 47 (1):43-9.
Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96 (10):2992-3003.
Jones S, Emmerson P, Maynard J et al. Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C-->T:A mutations. Hum Mol Genet 2002; 11 (23):2961-7.
Kajiwara K, Berson EL, Dryja TP. Digenic retinitis pigmentosa due to mutations at the unlinked peripherin/RDS and ROM1 loci. Science 1994; 264 (5165):1604-8.
Kaklamani V, Pasche B. Transforming Growth Factor Beta and breast cancer. Cancer Treat Res 2005; 126:129-56.
Kemp ZE, Carvajal-Carmona LG, Barclay E et al. Evidence of linkage to chromosome 9q22.33 in colorectal cancer kindreds from the United Kingdom. Cancer Res 2006; 66 (10):5003-6.
Kim YI, Pogribny IP, Salomon RN et al. Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Modulation by dietary folate. Am J Pathol 1996;
149 (4):1129-37.
Kinzler KW, Nilbert MC, Su LK et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253 (5020):661-5.
Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996; 87 (2):159-70.
Klingel R, Mittelstaedt P, Dippold WG et al. Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease. Gut 1991; 32 (12):1508-13.
Knoblauch H, Muller-Myhsok B, Busjahn A et al. A cholesterol-lowering gene maps to chromosome 13q. Am J Hum Genet 2000; 66 (1):157-66.
Knudson AG, Jr. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 1971; 68 (4):820-3.
Kosambi D. The estimation of map distances from recombination values. Ann Eugen 1944;
12:172-5.
Krontiris TG, Devlin B, Karp DD et al. An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 1993; 329 (8):517-23.
Krontiris TG, DiMartino NA, Colb M et al. Human restriction fragment length polymorphisms and cancer risk assessment. J Cell Biochem 1986; 30 (4):319-29.
Krontiris TG, DiMartino NA, Colb M et al. Unique allelic restriction fragments of the human Ha-ras locus in leukocyte and tumour DNAs of cancer patients. Nature 1985; 313 (6001):369-74.
Kruglyak L, Daly MJ, Reeve-Daly MP et al. Parametric and nonparametric linkage analysis: a unified multipoint approach. Am J Hum Genet 1996; 58 (6):1347-63.
Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet 1994; 3 Spec No:1487-95.
Laken SJ, Petersen GM, Gruber SB et al. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997; 17 (1):79-83.
Lamlum H, Al Tassan N, Jaeger E et al. Germline APC variants in patients with multiple colorectal adenomas, with evidence for the particular importance of E1317Q. Hum Mol Genet 2000; 9 (15):2215-21.
Laurent-Puig P, Beroud C, Soussi T. APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 1998; 26 (1):269-70.
Leach FS, Nicolaides NC, Papadopoulos N et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993; 75 (6):1215-25.
Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;
396 (6712):643-9.
Leppert M, Dobbs M, Scambler P et al. The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987; 238 (4832):1411-3.
Leslie A, Carey FA, Pratt NR et al. The colorectal adenoma-carcinoma sequence. Br J Surg 2002; 89 (7):845-60.
Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343 (2):78-85.
Liljegren A, Lindblom A, Rotstein S et al. Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut 2003; 52 (8):1140-7.
Lindblom A, Tannergard P, Werelius B et al. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 1993; 5 (3):279-82.
Lindgren G, Liljegren A, Jaramillo E et al. Adenoma prevalence and cancer risk in familial non-polyposis colorectal cancer. Gut 2002; 50 (2):228-34.
Lindor NM, Rabe K, Petersen GM et al. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. Jama 2005; 293 (16):1979-85.
Loeys BL, Chen J, Neptune ER et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005; 37 (3):275-81.
Lowy DR, Willumsen BM. Function and regulation of ras. Annu Rev Biochem 1993; 62:851-91.
Lynch HT, Boland CR, Gong G et al. Phenotypic and genotypic heterogeneity in the Lynch syndrome: diagnostic, surveillance and management implications. Eur J Hum Genet 2006; 14 (4):390-402.
Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med 2003; 348 (10):919-32.
Lynch HT, Drouhard TJ, Schuelke GS et al. Hereditary nonpolyposis colorectal cancer in a Navajo Indian family. Cancer Genet Cytogenet 1985; 15 (3-4):209-13.
Lynch HT, Shaw MW, Magnuson CW et al. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 1966; 117 (2):206-12.
Ma J, Stampfer MJ, Giovannucci E et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res 1997; 57 (6):1098-102.
Ma J, Stampfer MJ, Hennekens CH et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 1996; 94 (10):2410-6.
MacPhee M, Chepenik KP, Liddell RA et al. The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia. Cell 1995; 81 (6):957-66.
Markowitz S, Wang J, Myeroff L et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995; 268 (5215):1336-8.
McMichael AJ, McCall MG, Hartshorne JM et al. Patterns of gastro-intestinal cancer in European migrants to Australia: the role of dietary change. Int J Cancer 1980; 25 (4):431-7.
Morton NE. Sequential tests for the detection of linkage. Am J Hum Genet 1955; 7 (3):277-318.
Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990; 247 (4940):322-4.
Mueller-Koch Y, Vogelsang H, Kopp R et al. Hereditary non-polyposis colorectal cancer:
clinical and molecular evidence for a new entity of hereditary colorectal cancer. Gut 2005; 54 (12):1733-40.
Nadeau JH. Modifier genes in mice and humans. Nat Rev Genet 2001; 2 (3):165-74.
Neugut AI, Jacobson JS, De Vivo I. Epidemiology of colorectal adenomatous polyps. Cancer Epidemiol Biomarkers Prev 1993; 2 (2):159-76.
Nicolaides NC, Papadopoulos N, Liu B et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994; 371 (6492):75-80.
Nimmrich I, Friedl W, Kruse R et al. Loss of the PLA2G2A gene in a sporadic colorectal tumor of a patient with a PLA2G2A germline mutation and absence of PLA2G2A germline alterations in patients with FAP. Hum Genet 1997; 100 (3-4):345-9.
Nishisho I, Nakamura Y, Miyoshi Y et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991; 253 (5020):665-9.
Olsson L, Lindblom A. Family history of colorectal cancer in a Sweden county. Fam Cancer 2003; 2 (2):87-93.
Papadopoulos N, Nicolaides NC, Liu B et al. Mutations of GTBP in genetically unstable cells.
Science 1995; 268 (5219):1915-7.
Park KS, Mok JW, Kim JC. The 677C > T mutation in 5,10-methylenetetrahydrofolate reductase and colorectal cancer risk. Genet Test 1999; 3 (2):233-6.
Parkin DM, Bray F, Ferlay J et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55 (2):74-108.
Parsons R, Myeroff LL, Liu B et al. Microsatellite instability and mutations of the transforming growth factor beta type II receptor gene in colorectal cancer. Cancer Res 1995; 55 (23):5548-50.
Pasche B, Kaklamani V, Hou N et al. TGFBR1*6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol 2004; 22 (4):756-8.
Pasche B, Kolachana P, Nafa K et al. TbetaR-I(6A) is a candidate tumor susceptibility allele.
Cancer Res 1999; 59 (22):5678-82.
Pasche B, Luo Y, Rao PH et al. Type I transforming growth factor beta receptor maps to 9q22 and exhibits a polymorphism and a rare variant within a polyalanine tract. Cancer Res 1998; 58 (13):2727-32.
Peltomaki P. Deficient DNA mismatch repair: a common etiologic factor for colon cancer.
Hum Mol Genet 2001; 10 (7):735-40.
Peltomaki P. Lynch syndrome genes. Fam Cancer 2005; 4 (3):227-32.
Peltomaki P, Aaltonen LA, Sistonen P et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993; 260 (5109):810-2.
Peltomaki P, Gao X, Mecklin JP. Genotype and phenotype in hereditary nonpolyposis colon cancer: a study of families with different vs. shared predisposing mutations. Fam Cancer 2001;
1 (1):9-15.
Peltomaki P, Vasen H. Mutations associated with HNPCC predisposition -- Update of ICG-HNPCC/INSiGHT mutation database. Dis Markers 2004; 20 (4-5):269-76.
Potter JD. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999; 91 (11):916-32.
Powell SM, Zilz N, Beazer-Barclay Y et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359 (6392):235-7.
Ravenel JD, Broman KW, Perlman EJ et al. Loss of imprinting of insulin-like growth factor-II (IGF2) gene in distinguishing specific biologic subtypes of Wilms tumor. J Natl Cancer Inst 2001; 93 (22):1698-703.
Riazuddin S, Castelein CM, Ahmed ZM et al. Dominant modifier DFNM1 suppresses recessive deafness DFNB26. Nat Genet 2000; 26 (4):431-4.
Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273 (5281):1516-7.
Rodrigues NR, Rowan A, Smith ME et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci U S A 1990; 87 (19):7555-9.
Rodriguez-Bigas MA, Boland CR, Hamilton SR et al. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst 1997; 89 (23):1758-62.
Samowitz WS, Curtin K, Leppert MF et al. Uncommon TGFBRI allele is not associated with increased susceptibility to colon cancer. Genes Chromosomes Cancer 2001; 32 (4):381-3.
Samowitz WS, Sweeney C, Herrick J et al. Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers. Cancer Res 2005; 65 (14):6063-9.
Sampson JR, Dolwani S, Jones S et al. Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH. Lancet 2003; 362 (9377):39-41.
Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977; 74 (12):5463-7.
Scott RJ, McPhillips M, Meldrum CJ et al. Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. Am J Hum Genet 2001; 68 (1):118-27.
Sieber OM, Lipton L, Crabtree M et al. Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 2003; 348 (9):791-9.
Sjöblom T, Jones S, Wood LD et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006; 314 (5797):268-74.
Skoglund J, Djureinovic T, Zhou XL et al. Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet 2006; 43 (2):e7.
Slattery ML, Potter JD, Samowitz W et al. Methylenetetrahydrofolate reductase, diet, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev 1999; 8 (6):513-8.
Slupska MM, Baikalov C, Luther WM et al. Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage. J Bacteriol 1996; 178 (13):3885-92.
Sobel E, Lange K. Descent graphs in pedigree analysis: applications to haplotyping, location scores, and marker-sharing statistics. Am J Hum Genet 1996; 58 (6):1323-37.
Socialstyrelsen. Cancer i siffror.
Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993;
52 (3):506-16.
Stefanovska AM, Efremov GD, Dimovski AJ et al. TbetaR-I(6A) polymorphism is not a tumor susceptibility allele in Macedonian colorectal cancer patients. Correspondence re: B. Pasche et al. Type I TbetaR-I(6A) Is a Candidate Tumor Susceptibility Allele. Cancer Res., 58: 2727-2732, 1998. Cancer Res 2001; 61 (22):8351-2.
Stirbu I, Kunst AE, Vlems FA et al. Cancer mortality rates among first and second generation migrants in the Netherlands: Convergence toward the rates of the native Dutch population. Int J Cancer 2006; 119 (11):2665-72.
Suter CM, Martin DI, Ward RL. Germline epimutation of MLH1 in individuals with multiple cancers. Nat Genet 2004; 36 (5):497-501.
Takagi Y, Kohmura H, Futamura M et al. Somatic alterations of the DPC4 gene in human colorectal cancers in vivo. Gastroenterology 1996; 111 (5):1369-72.
Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (part I). J Natl Cancer Inst 1998a;
90 (20):1529-36.
Taketo MM. Cyclooxygenase-2 inhibitors in tumorigenesis (Part II). J Natl Cancer Inst 1998b;
90 (21):1609-20.
Tannergard P, Liu T, Weger A et al. Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer. Hum Genet 1997; 101 (1):51-5.
Tannergard P, Zabarovsky E, Stanbridge E et al. Sublocalization of a locus at 3p21.3-23 predisposing to hereditary nonpolyposis colon cancer. Hum Genet 1994; 94 (2):210-4.
Tenesa A, Campbell H, Barnetson R et al. Association of MUTYH and colorectal cancer. Br J Cancer 2006; 95 (2):239-42.
Terry P, Giovannucci E, Michels KB et al. Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst 2001; 93 (7):525-33.
Tomlinson I, Rahman N, Frayling I et al. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology 1999; 116 (4):789-95.
Torrance CJ, Jackson PE, Montgomery E et al. Combinatorial chemoprevention of intestinal neoplasia. Nat Med 2000; 6 (9):1024-8.
Toyota M, Ahuja N, Ohe-Toyota M et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999; 96 (15):8681-6.
Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary
nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96 (4):261-8.